Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development.
about
Use of Bayesian Markov chain Monte Carlo methods to estimate EQ-5D utility scores from EORTC QLQ data in myeloma for use in cost-effectiveness analysis.Politics and its intersection with coverage with evidence development: a qualitative analysis from expert interviews.Value of Information Analysis Applied to the Economic Evaluation of Interventions Aimed at Reducing Juvenile Delinquency: An IllustrationThe need to balance merits and limitations from different disciplines when considering the stepped wedge cluster randomized trial design.Healthcare Databases in Thailand and Japan: Potential Sources for Health Technology Assessment Research.Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the kneeWhen does NICE recommend the use of health technologies within a programme of evidence development? : a systematic review of NICE guidancePricing and reimbursement frameworks in Central Eastern Europe: a decision tool to support choices.Cost-effectiveness and value of information analysis of nutritional support for preventing pressure ulcers in high-risk patients: implement now, research later.Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review.Introduction of a new health technology into a provincial health system: A case study of insulin pump therapy.The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment.How to design the cost-effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework.Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis.Characterising Uncertainty in the Assessment of Medical Devices and Determining Future Research Needs.Analytic approaches for research priority-setting: issues, challenges and the way forward.Real-World Evidence: A Comparison of the Australian Herceptin Program and Clinical Trials of Trastuzumab for HER2-Positive Metastatic Breast Cancer.Value of Information: We've Got Speed, What More Do We Need?Using HTA and guideline development as a tool for research priority setting the NICE way: reducing research waste by identifying the right research to fund.Decision uncertainty and value of further research: a case-study in fenestrated endovascular aneurysm repair for complex abdominal aortic aneurysms.Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals.
P2860
Q30912145-08DE9010-E09C-4821-A61E-F3ABADC0B4CAQ34623074-6120B504-DB5F-42BA-A0FB-0E5BB5425878Q35683100-E0483D9D-CBF2-4F94-BE23-26E355B63F0EQ35826614-541A22B6-B5F9-4E00-A4F7-18D508FE0960Q35839046-65A5CA45-C395-4973-9466-9DA47607891CQ36299326-C9B99A0C-2A16-4F34-8711-AFEEEA68EBE9Q36579754-455AB266-8C77-4974-A185-1F29EED7EC5EQ38223213-3C92BE02-28E3-4299-B9EE-D49586DE7C12Q38343692-FACEF7F2-C572-4B9D-9ECC-68ADFDBC6AECQ38517704-8001DBF7-1AF4-49AD-8687-1452741B73E9Q38557834-25AFE6B9-B788-41CB-95A0-FEA72E767B68Q38604306-0D3454E6-1563-4F1E-B9F1-1990090A3F79Q38638180-6BE820DE-749F-446E-91FD-2F4582F7CFB3Q38669137-62FFC641-C7AE-4CC1-82F0-F1492513A118Q38764032-54EBF1AF-A153-46DB-BD12-3640827ED06CQ38960831-A2DA2285-F693-460B-87CF-1535083AC0BFQ39748463-F7B9C680-1A09-4CBB-A74E-83511F193BF7Q50939811-50013B39-1F21-4C8E-90CD-64088CF777EBQ51742037-AA4877B7-9AF4-476B-A176-B692370C77E3Q52311713-F9D7494A-73EF-4E52-942D-A11DC92EF846Q55210410-5904A45F-D211-4A73-95CD-038150E6B1D3
P2860
Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Informing a decision framework ...... ramme of evidence development.
@en
type
label
Informing a decision framework ...... ramme of evidence development.
@en
prefLabel
Informing a decision framework ...... ramme of evidence development.
@en
P2093
P356
P1476
Informing a decision framework ...... ramme of evidence development.
@en
P2093
E Spackman
P356
10.3310/HTA16460
P577
2012-01-01T00:00:00Z